Mechanistic/mammalian target of rapamycin inhibition suppresses mitochondrial protein expressions and respiratory capacity in cultured skeletal muscle cells.

The mechanistic/mammalian target of rapamycin (mTOR) is a well-known serine/threonine kinase that activates muscle protein synthesis in response to anabolic conditions after exercise or nutrition intake. Rapamycin, a canonical inhibitor of mTOR complex 1 (mTORC1), induces mitochondrial dysfunction in addition to attenuating the muscle protein synthesis response. These findings suggest that mTORC1 contributes to mitochondrial homeostasis; however, the involvement of mTOR complex 2 (mTORC2) and the relationship between mTORC1 and mTORC2 are unclear. Therefore, this study was conducted to determine the role of the mTOR complex in mitochondrial function in skeletal muscle cells using rapamycin and AZD8055, as an ATP-competitive mTOR kinase inhibitor that inhibits both mTORC1 and mTORC2. AZD8055 treatment more significantly reduced the expression of proteins associated with mitochondrial oxidative phosphorylation, fusion, and fission, and decreased the respiratory capacity than rapamycin treatment. In conclusion, mTORC1 and mTORC2 cooperatively regulate mitochondrial protein expressions and respiratory function in skeletal muscle cells. [ABSTRACT FROM AUTHOR]